166 related articles for article (PubMed ID: 34810077)
1. Impact of preoperative systemic immune-inflammation Index on oncologic outcomes in bladder cancer patients treated with radical cystectomy.
Grossmann NC; Schuettfort VM; Pradere B; Rajwa P; Quhal F; Mostafaei H; Laukhtina E; Mori K; Motlagh RS; Aydh A; Katayama S; Moschini M; Fankhauser CD; Hermanns T; Abufaraj M; Mun DH; Zimmermann K; Fajkovic H; Haydter M; Shariat SF
Urol Oncol; 2022 Mar; 40(3):106.e11-106.e19. PubMed ID: 34810077
[TBL] [Abstract][Full Text] [Related]
2. Impact of the preoperative modified Glasgow Prognostic Score on disease outcome after radical cystectomy for urothelial carcinoma of the bladder.
Schuettfort VM; Gust K; D'Andrea D; Quhal F; Mostafaei H; Laukhtina E; Mori K; Rink M; Abufaraj M; Karakiewicz PI; Luzzago S; Rouprêt M; Enikeev D; Zimmermann K; Deuker M; Moschini M; Sari Motlagh R; Grossmann NC; Katayama S; Pradere B; Shariat SF
Minerva Urol Nephrol; 2022 Jun; 74(3):302-312. PubMed ID: 34114784
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.
Mori K; Schuettfort VM; Katayama S; Laukhtina E; Pradere B; Quhal F; Sari Motlagh R; Mostafaei H; Grossmann NC; Rajwa P; Teoh JY; Resch I; Fajkovic H; Moschini M; D'andrea D; Abufaraj M; Karakiewicz PI; Lotan Y; Scherr D; Egawa S; Compérat E; Shariat SF;
Ann Surg Oncol; 2022 Aug; 29(8):5307-5316. PubMed ID: 35347517
[TBL] [Abstract][Full Text] [Related]
4. Impact of systemic Immune-inflammation Index on oncologic outcomes in patients treated with radical prostatectomy for clinically nonmetastatic prostate cancer.
Rajwa P; Schuettfort VM; D'Andrea D; Quhal F; Mori K; Katayama S; Laukhtina E; Pradere B; Motlagh RS; Mostafaei H; Grossmann NC; Huebner N; Aulitzky A; Mun DH; Briganti A; Karakiewicz PI; Fajkovic H; Shariat SF
Urol Oncol; 2021 Nov; 39(11):785.e19-785.e27. PubMed ID: 34116934
[TBL] [Abstract][Full Text] [Related]
5. Is Systemic Immune-Inflammation Index a Real Non-Invasive Biomarker to Predict Oncological Outcomes in Patients Eligible for Radical Cystectomy?
Russo P; Marino F; Rossi F; Bizzarri FP; Ragonese M; Dibitetto F; Filomena GB; Marafon DP; Ciccarese C; Iacovelli R; Pandolfo SD; Aveta A; Cilio S; Napolitano L; Foschi N
Medicina (Kaunas); 2023 Nov; 59(12):. PubMed ID: 38138166
[No Abstract] [Full Text] [Related]
6. Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
Laukhtina E; Schuettfort VM; D'Andrea D; Pradere B; Mori K; Quhal F; Sari Motlagh R; Mostafaei H; Katayama S; Grossmann NС; Rajwa P; Zeinler F; Abufaraj M; Moschini M; Zimmermann K; Karakiewicz PI; Fajkovic H; Scherr D; Compérat E; Nyirady P; Rink M; Enikeev D; Shariat SF
Mol Carcinog; 2022 Jan; 61(1):5-18. PubMed ID: 34587660
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy.
Schuettfort VM; Pradere B; D'Andrea D; Grossmann NC; Quhal F; Mostafaei H; Laukhtina E; Mori K; Rink M; Karakiewicz PI; Motlagh RS; Katayama S; Lotan Y; Scherr D; Abufaraj M; Fajkovica H; Compérat E; Enikeev D; Shariat SF
J Urol; 2021 Nov; 206(5):1122-1131. PubMed ID: 34181469
[TBL] [Abstract][Full Text] [Related]
8. A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma.
Schuettfort VM; D'Andrea D; Quhal F; Mostafaei H; Laukhtina E; Mori K; König F; Rink M; Abufaraj M; Karakiewicz PI; Luzzago S; Rouprêt M; Enikeev D; Zimmermann K; Deuker M; Moschini M; Sari Motlagh R; Grossmann NC; Katayama S; Pradere B; Shariat SF
BJU Int; 2022 Feb; 129(2):182-193. PubMed ID: 33650265
[TBL] [Abstract][Full Text] [Related]
9. The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy.
Mori K; Schuettfort VM; Katayama S; Laukhtina E; Pradere B; Quhal F; Sari Motlagh R; Mostafaei H; Grossmann NC; Rajwa P; König F; Aydh A; Soria F; Moschini M; Karakiewicz PI; Lotan Y; Scherr D; Haydter M; Nyirady P; Teoh JYC; Egawa S; Compérat E; Shariat SF
Eur Urol Focus; 2022 Jul; 8(4):972-979. PubMed ID: 34454852
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy.
D'Andrea D; Moschini M; Gust KM; Abufaraj M; Özsoy M; Mathieu R; Soria F; Briganti A; Rouprêt M; Karakiewicz PI; Shariat SF
J Surg Oncol; 2017 Mar; 115(4):455-461. PubMed ID: 28105663
[TBL] [Abstract][Full Text] [Related]
11. Immune-inflammatory-nutritional status predicts oncologic outcomes after radical cystectomy for urothelial carcinoma of bladder.
Teke K; Avci IE; Cinar NB; Baynal EA; Bosnali E; Polat S; Yilmaz H; Kara O; Dillioglugil O
Actas Urol Esp (Engl Ed); 2023 Sep; 47(7):430-440. PubMed ID: 36731820
[TBL] [Abstract][Full Text] [Related]
12. Impact of preoperative serum albumin-globulin ratio on disease outcome after radical cystectomy for urothelial carcinoma of the bladder.
Schuettfort VM; D Andrea D; Quhal F; Mostafaei H; Laukhtina E; Mori K; Sari Motlagh R; Rink M; Abufaraj M; Karakiewicz PI; Luzzago S; Rouprêt M; Chlosta P; Babjuk M; Deuker M; Moschini M; Shariat SF; Pradere B
Urol Oncol; 2021 Apr; 39(4):235.e5-235.e14. PubMed ID: 33189530
[TBL] [Abstract][Full Text] [Related]
13. Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer.
Schuettfort VM; Pradere B; Trinh QD; D'Andrea D; Quhal F; Mostafaei H; Laukhtina E; Mori K; Sari Motlagh R; Rink M; Karakiewicz PI; Chlosta P; Yuen-Chun Teoh J; Lotan Y; Scherr D; Abufaraj M; Moschini M; Shariat SF
Cancer Immunol Immunother; 2022 Jan; 71(1):85-95. PubMed ID: 34023914
[TBL] [Abstract][Full Text] [Related]
14. Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy.
Lucca I; Hofbauer SL; Leitner CV; de Martino M; Özsoy M; Susani M; Shariat SF; Klatte T
Urology; 2016 Sep; 95():132-8. PubMed ID: 27316373
[TBL] [Abstract][Full Text] [Related]
15. Retrospective study of systemic immune-inflammation index in muscle invasive bladder cancer: initial results of single centre.
Gorgel SN; Akin Y; Koc EM; Kose O; Ozcan S; Yilmaz Y
Int Urol Nephrol; 2020 Mar; 52(3):469-473. PubMed ID: 31659597
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of the systemic immune-inflammation index for patients with bladder cancer after radical cystectomy.
Zhang S; Du J; Zhong X; Tan P; Xu H; Zhang J; Jin D; Li Y; Le W; Xiong X; Lin T; Wei Q
Front Immunol; 2022; 13():1072433. PubMed ID: 36524107
[TBL] [Abstract][Full Text] [Related]
17. Preoperative models incorporating the systemic immune-inflammation index for predicting prognosis and muscle invasion in patients with non-metastatic upper tract urothelial carcinoma.
Kobayashi S; Ito M; Takemura K; Suzuki H; Yonese I; Koga F
Int J Clin Oncol; 2022 Mar; 27(3):574-584. PubMed ID: 34860315
[TBL] [Abstract][Full Text] [Related]
18. Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy.
Russo P; Palermo G; Iacovelli R; Ragonese M; Ciccarese C; Maioriello G; Fantasia F; Bizzarri FP; Marino F; Moosavi K; Nigro D; Filomena GB; Gavi F; Rossi F; Pinto F; Racioppi M; Foschi N
Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339402
[TBL] [Abstract][Full Text] [Related]
19. Impact of Preoperative Plasma Potassium Levels on Oncological Outcomes, Major Complications, and 30-Day Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy.
Klemm J; Shariat SF; Laukhtina E; Rajwa P; Vetterlein MW; Schuettfort VM; von Deimling M; Dahlem R; Fisch M; Rink M
Clin Genitourin Cancer; 2024 Jun; 22(3):102079. PubMed ID: 38614853
[TBL] [Abstract][Full Text] [Related]
20. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
